The inhibition of NFκB (Figure 4A) and PI3K/Akt in HD fibroblasts (Figure 4B) decreased in a dose-dependent manner the production of IL-6 driven by the combined action of IL-17A and TGF-β. This evidence concerns the gene TGFB1 and Huntington disease.